130 results
Page 3 of 7
8-K
EX-1.1
b61 4evioovp97z
29 Mar 12
NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds
12:00am
8-K
EX-10.2
t5dn8kzrwop
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
8-K
EX-1.1
0pzw1snopaouc
20 Jul 11
NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
12:00am
425
EX-1.1
cq8ns
20 Jul 11
Business combination disclosure
12:00am
8-K
EX-2.1
rw7cw63kqpet 85fu72
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
hai2vb7o9fq0lp
14 Jul 11
Business combination disclosure
12:00am
8-K
EX-10.3
y4g wmvq9
24 Jan 11
Completion of Acquisition or Disposition of Assets
12:00am
424B3
5tw2 ydvwcsw2o4644
17 Dec 10
Prospectus supplement
12:00am
424B5
a71iav4v0ny
17 Nov 10
Prospectus supplement for primary offering
12:00am
425
EX-10.1
zz5n8sc7m4xf4y9kw
16 Nov 10
Business combination disclosure
12:00am